Literature DB >> 28954129

Trigeminal trophic syndrome.

Arunprasath Palanisamy1, Sunjanaa Dhepa Rajappavu1, Srivenkateswaran Kothandapany1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28954129      PMCID: PMC5595627          DOI: 10.1590/abd1806-4841.20175484

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


× No keyword cloud information.
Dear Editor, An 80-year-old male presented with chronic non-healing ulcers involving the left side of the scalp and forehead for three months. The lesions were associated with intractable itching and vague crawling sensation. Following that, he started picking and rubbing his skin, which resulted in ulcers. His medical history was suggestive of herpes zoster involving the left ophthalmic (V1) branch of the trigeminal nerve for nine months. Physical examination revealed a 4x3-cm ulcer involving the left frontal aspect of the scalp and two other small ulcers, one involving the center of the scalp and the other above the lateral aspect of the left eyebrow, corresponding to the ophthalmic (V1) branch of the trigeminal nerve. The latter lesion showed areas of post inflammatory depigmentation (Figure 1). Routine hematological and biochemical investigations were within normal limits. Head MRI revealed age-related cortical atrophy and was otherwise normal. Systemic examination revealed no abnormality. A diagnosis of trigeminal trophic syndrome (TTS) was entertained. The patient was treated with occlusive dressings, topical antibiotics, and carbamazepine with complete resolution of the lesions within three weeks (Figure 2).
Figure 1

Crescent-shaped ulcer involving the left frontal scalp and a small ulcer above the lateral aspect of the eyebrow

Figure 2

Healed ulcer after three weeks of treatment

Crescent-shaped ulcer involving the left frontal scalp and a small ulcer above the lateral aspect of the eyebrow Healed ulcer after three weeks of treatment TTS is a rare clinical entity characterized by unilateral facial ulceration involving the trigeminal nerve (TN) territory following damage to its central or peripheral nerve structure. The classical clinical triad of TTS consists of trigeminal anaesthesia, facial paraesthesia, and crescent shaped ulcers.[1] The presenting features will be that of picking, rubbing, or scratching sensations on the affected areas secondary to hypoesthesia, paraesthesia, or pain resulting from damage of the sensory trigeminal fibers.[2] Adolf Wallenberg was the first to describe TTS in 1895 in a patient with lateral medullary infarction.[3] TTS is frequently triggered by iatrogenic causes, usually following procedures for pain management in trigeminal neuralgia.[4] Other causes include stroke, acoustic neuroma, post-infectious encephalitis, trauma, amyloid deposits in the TN, and infections.[1,4,5] Herpes zoster and leprosy are also major dermatological causes for TTS.[5] Initially, TTS lesions were believed to be a sequel of impaired nerve fibers resulting in the loss of neuronal trophic factors.[6] Later, researchers realized that the condition is caused by self manipulation of the desensate itchy skin in a reflexive action to get rid of the troublesome dysethesias.[3,6] Although TTS characteristically affects the ipsilateral nasal ala, cheeks, and upper lip, involving the V2 or V3 dermatomes, it can appear anywhere in the trigeminal innervation territory.[6] TTS following herpes zoster involving the scalp and forehead is a less common presentation. Differential diagnosis of TTS includes various diseases manifesting as facial ulcers such as squamous cell carcinoma, basal cell carcinoma, infections, vasculitis, pyoderma gangrenosum, and factitial dermatitis.[1,2,4,5] Treatment should be centered on behavioral modification intended to reduce self-induced trauma.[7,8] Occlusive dressings can also prevent handling and perpetuation of the skin lesions by the patients. Pharmacotherapy with carbamazepine, amitriptyline, diazepam, chlorpromazine, and pimozide has been used with varying results.[8] Other reported modalities of management include hydrocolloid dressings, transcutaneous electrical nerve stimulation, plastic surgery with innervated flaps, and negative pressure wound therapy.[2,4,5] The present case was successfully managed with counseling, occlusive dressings, and carbamazepine.
  8 in total

1.  Trigeminal trophic syndrome.

Authors:  Robert Slater
Journal:  Int J Dermatol       Date:  2006-07       Impact factor: 2.736

2.  Trigeminal trophic syndrome: a rare entity.

Authors:  Sunil N Mishra; Chitra S Nayak; Deepal J Deshpande; Rickson R Pereira
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Nov-Dec       Impact factor: 2.545

3.  Trigeminal trophic syndrome with histopathologic correlation.

Authors:  Lindsey B Dolohanty; Steven J Richardson; David N Herrmann; John Markman; Mary Gail Mercurio
Journal:  Cutis       Date:  2015-03

Review 4.  Neuropathic itch.

Authors:  Anne Louise Oaklander
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 5.  Trigeminal trophic syndrome.

Authors:  R M Rashid; A Khachemoune
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-07       Impact factor: 6.166

6.  Trigeminal trophic syndrome: a report of two cases with review of literature.

Authors:  A Elloumi-Jellouli; S Ben Ammar; S Fenniche; M Zghal; H Marrak; I Mokhtar
Journal:  Dermatol Online J       Date:  2003-12

7.  The trigeminal trophic syndrome: an unusual cause of face pain, dysaesthesias, anaesthesia and skin/soft tissue lesions.

Authors:  I Garza
Journal:  Cephalalgia       Date:  2008-06-28       Impact factor: 6.292

8.  Trigeminal trophic syndrome.

Authors:  Parimalam Kumar; Jayakar Thomas
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

  8 in total
  1 in total

1.  Postherpetic Trigeminal Trophic Syndrome: A Case Report.

Authors:  Jae-Ho Lee; Ji-An Uh; Joong-Ho Kim; Ho-Young Kim; Myoung-Shin Kim; Un-Ha Lee; Soo-Kyung Lee
Journal:  Ann Dermatol       Date:  2022-10       Impact factor: 0.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.